Table 5. Multivariate association of adiponectin levels with non-calcified plaques.

	Non-calcified plaques
	estimate	95% CI	p
Model 1*	−0.091	−0.126 to −0.057	<0.0001
Model 2†	−0.082	−0.117 to −0.048	<0.0001
Model 3‡	−0.082	−0.120 to −0.044	<0.0001
Model 4§	−0.074	−0.112 to −0.036	0.0001
Model 5∥	−0.076	−0.115 to −0.038	0.0001

Estimate and 95% CI for decrease in the number of non-calcified plaques for an 1 µg/ml increase in serum adiponectin levels. Full model 5 (including all parameters) is shown in Table S3 of the supplement.

^*adjusted for age, sex and BMI.

^†adjusted for age, sex, BMI, hypertension, diabetes mellitus, smoking and family history of CAD.

^‡adjusted for age, sex, BMI, hypertension, diabetes mellitus, smoking, family history of CAD, LDL-C, HDL-C, triglycerides and hsCRP levels.

^§adjusted for age, sex, BMI, hypertension, diabetes mellitus, smoking, family history of CAD, LDL-C, HDL-C, triglycerides, hsCRP levels and medication.

^∥adjusted for age, sex, BMI, hypertension, diabetes mellitus, smoking, family history of CAD, LDL-C, HDL-C, triglycerides, hsCRP levels, medication and PAT volume.